[Albumin cobalt binding ability in assessment of myocardial ischemia in patients with acute coronary syndrome].
Verification of the diagnosis of coronary artery disease (CAD) is based mostly on instrumental diagnostic techniques. Presently, there are no laboratory tests officially recommended for the diagnostics of myocardial ischemia (MI). Biochemical methods that would be able to verify MI in patients with suspected CAD have been under development since the 1990s. Ischemically modified albumin--IMA (Albumin Cobalt Binding test), glycogen phosphorylase BB, and free fatty acid-binding protein have been proposed as laboratory markers of MI. The article discusses advantages and disadvantages of IMA for diagnostics of MI in patients with acute coronary syndrome.
Kremneva
L V
LV
Kuznetsov
V A
VA
D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D003035:Cobalt / Q000378:metabolism*; D003327:Coronary Disease / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D011379:Prognosis; D011485:Protein Binding; D012372:ROC Curve; D012709:Serum Albumin / Q000378:metabolism*; D013577:Syndrome
D015415:Biomarkers; D012709:Serum Albumin; D003035:Cobalt